4//SEC Filing
Browne L Daniel 4
Accession 0001479290-18-000023
CIK 0001479290other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:21 PM ET
Size
7.9 KB
Accession
0001479290-18-000023
Insider Transaction Report
Form 4
Browne L Daniel
DirectorCEO and President
Transactions
- Award
Common Stock
2018-02-08+28,250→ 161,565 total - Award
Employee Stock Option (Right to Buy)
2018-02-08+169,000→ 169,000 totalExercise: $29.15Exp: 2028-02-07→ Common Stock (169,000 underlying)
Holdings
- 409(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from March 15, 2018, subject to Mr. Browne's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]These shares are held by the Dan and Brenda Browne Living Trust. Mr. Browne is a Trustee of the Dan and Brenda Browne Living Trust.
- [F3]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from February 8, 2018, subject to Mr. Browne's Continuous Service (as defined in the Plan) on each vesting date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001597583
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 9:21 PM ET
- Size
- 7.9 KB